Okay, let's tackle this question about the best treatment for Kawasaki's disease. First, I need to recall what Kawasaki's disease is. It's a systemic vasculitis that mainly affects children, right? The main concern is the risk of coronary artery aneurysms, so treatment should aim to reduce inflammation and prevent those complications.

The question asks for the best treatment. From what I remember, the standard treatment is intravenous immunoglobulin (IVIG) along with aspirin. IVIG helps modulate the immune response and reduce inflammation. Aspirin is used for its anti-inflammatory and anticoagulant properties. High-dose aspirin initially to reduce inflammation, then low-dose for anticoagulation if there are no complications.

Wait, but why IVIG specifically? I think IVIG works by neutralizing cytokines and immune complexes, which are elevated in Kawasaki's. It's given in a single high dose. Other treatments might include corticosteroids or other immunosuppressants, but those are usually when IVIG isn't effective. So the primary treatment is definitely IVIG plus aspirin.

Now, the options aren't listed, but the correct answer is supposed to be IVIG and aspirin. The other options might be things like corticosteroids, antibiotics, or just aspirin alone. Let me check each wrong option. Corticosteroids are not first-line because they don't reduce coronary artery aneurysms and might even increase the risk. Antibiotics are wrong because Kawasaki's is not bacterial. Aspirin alone is insufficient as monotherapy; IVIG is necessary for the immune modulation.

The clinical pearl here is that the combination of IVIG and aspirin is the cornerstone of treatment. Also, early administration of IVIG is crucial to prevent coronary artery complications. If a patient doesn't respond to IVIG, then other therapies like corticosteroids or infliximab might be considered, but that's a second-line approach.

So putting it all together, the best treatment is IVIG plus aspirin. The correct answer should be the option that includes both. Let me make sure I didn't mix up any details. Yes, IVIG is the mainstay, and aspirin is the primary antiplatelet agent used here.

**Core Concept**
Kawasaki disease is an acute systemic vasculitis of childhood, primarily affecting medium-sized arteries including coronary arteries. The cornerstone of treatment is intravenous immunoglobulin (IVIG) to modulate the hyperinflammatory immune response and reduce coronary artery aneurysm risk.

**Why the Correct Answer is Right**
IVIG administered at 2 g/kg over 10–12 hours within the first 10 days of illness significantly reduces inflammation and prevents coronary artery complications. It works by neutralizing pathogenic cytokines (e.g., IL-6, TNF-α) and modulating immune cell activity. High-dose aspirin (80–100 mg/kg/day) initially suppresses inflammation, followed by low-dose (3–5 mg/kg/day) for anticoagulation if no coronary artery abnormalities are present.

**Why Each Wrong Option is Incorrect**
**Option A:** Corticosteroids (e.g., prednisone) are not first-line; they may increase risk of coronary artery aneurysms when used alone.
**Option B:** Antib

✓ Correct Answer: B. I.V. immunoglobulins